Related Experiment Videos
[Gastroesophageal reflux and lung diseases]
1Pneumologische Abteilung der Klinik Barmelweid/Aarau.
Pneumologie (Stuttgart, Germany)
|February 1, 1990
Summary
Gastro-oesophageal reflux (GER) can worsen lung conditions like asthma and chronic bronchitis by causing inflammation and airway obstruction. Recognizing this link is key to effective treatment and breaking a harmful cycle.
Area of Science:
- Pulmonary Medicine
- Gastroenterology
Context:
- Gastro-oesophageal reflux (GER) is increasingly recognized as a factor in chronic respiratory diseases.
- A bidirectional relationship exists between GER and obstructive airway diseases.
Purpose:
- To elucidate the detrimental interaction between GER and pulmonary conditions.
- To highlight the prevalence and diagnostic methods for GER in respiratory patients.
- To outline current treatment strategies for GER in this population.
Summary:
- GER can lead to chronic bronchopulmonary inflammation and airway obstruction through aspiration and vagal reflexes.
- Obstructive airway diseases contribute to GER via anatomical and physiological changes.
- Prevalence of GER is significantly higher (30-40%) in asthma and chronic bronchitis patients compared to the general population (5-10%).
- Symptoms like productive cough, nocturnal respiratory issues, and hoarseness suggest a link.
- Diagnosis can be established through modified Bernstein tests, radionuclide studies, and sleep studies.
- Treatment includes antireflux diets, H2-antagonists, and antacids, often avoiding surgery.
Impact:
- Routine consideration of GER in pulmonary patients can lead to earlier diagnosis and effective management.
- Interrupting the GER-pulmonary disease cycle can improve patient outcomes.
- Understanding this comorbidity is crucial for comprehensive patient care.